Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Pertuzumab Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027Pertuzumab Market Report Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
Pertuzumab is a recombinant monoclonal antibody that acts as an antineoplastic agent, which targets the human epidermal growth factor receptor 2 protein known as HER2. The drug blocks signaling pathways that leads to cell growth arrest and apoptosis (cell destruction) * The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology. Request a sample copy of this report: https://www.coherentmarketinsights.com/ Moreover, development of novel anticancer drug delivery technologies is expected to boost growth of the market. For instance, in July 2018, Gentech, Inc., in partnership with Halozyme Therapeutics, Inc., used proprietary ENHANZE drug-delivery technology of Halozyme Therapeutics, Inc., for subcutaneous administration of fixed-dose combination of pertuzumab (PERJETA) and trastuzumab (Herceptin). This study is under clinical phase III trial. ENHANZE technology aids in reducing the need for multiple injections and reduces time required for drug administration. Moreover, according to a study published in the journal Oncology, September 2015, although the use of pertuzumab with docetaxel and trastuzumab as first-line therapy for HER2 positive breast cancer has been shown to yield a substantial survival benefit, the therapy is not cost effective in the U.S. Also, according to the same source, the cost of treating HER2 positive breast cancer with pertuzumab and other drugs is US$ 509,845 and that with only docetaxel and trastuzumab is US$ 135,092. Browse Research Report: https://www.coherentmarketinsights.com/ Pertuzumab Market– Regional Analysis On the basis of region, the global pertuzumab market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Furthermore, Asia Pacific is expected to witness significant growth in the global pertuzumab market, owing to increasing awareness of breast cancer and its management. For instance, in November 2016, India launched National Cancer Screening Program to increase awareness and early detection of breast cancer. Buy-Now this research report: https://www.coherentmarketinsights.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|